Delivery Order SPE2DB24D3015-SPE2DB25FFXBJ

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,812.53, is for the delivery of AVAPRO 300 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The $1,671.45 firm fixed-price delivery order is for AVAPRO 150 MG TABLET 30S, a medication used to treat high blood pressure. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of AVAPRO 150 MG TABLET 30S. The contract is a Delivery Order under the existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,316.88 and is for the delivery of AVAPRO 150 MG TABLET 30S, a generic medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract has a ceiling value of $1,811.45 and a period of performance through March 4, 2025. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,867.88, is for the delivery of Irbesartan 150 mg tablets. It is a firm fixed-price contract with an ultimate completion date of May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count packages of the medication Irbesartan 300 mg tablets, with a ceiling value of $8,121.41 and a performance period ending on May 13, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition....
This federal contract award, valued at $2,202.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg Tablets in 90-count packages, with a completion date of April 28, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH7JY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Irbesartan 150 mg tablets, a cardiovascular medication, with a total ceiling value of $6,617.42 and a completion date of December 4, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,637.97 Firm Fixed Price Delivery Order is for the supply of 90-count bottles of 300 mg Irbesartan tablets. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXBJ
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,769.18 firm fixed-price contract is for the delivery of AVAPRO 300 MG TABLET 30S, a cardiovascular medication, with a period of performance through November 2024.

The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely one of many such orders under that broader IDC framework.

Generated 5/20/25, 2:10 PM